HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) – CASE REPORT

  • Irena Bricl Zavod Republike Slovenije za transfuzijsko medicino Šlajmerjeva 6 1000 Ljubljana
  • Ksenija Ogrizek-Pelkič Služba za ginekologijo in perinatologijo Oddelek za perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2000 Maribor
  • Andrej Vogler Ginekološka klinika Klinični center Šlajmerjeva 3 1525 Ljubljana
Keywords: RhD immunization, hemolytic disease of the fetus and newborn, prevention of RhD immunization, anti-D antibody titer, test ADCC, exchange transfusion, case report

Abstract

Background. Hemolytic disease of the fetus and newborn (HDFN) develops because of the passage of maternal erythrocyte alloantibodies through the placenta. These antibodies cause a reduction of the erythrocyte life span in the fetus and newborn. This severe form of the disease is most commonly caused by anti-D antibodies. Besides those, the hemolytic disease can also be caused by anti-K, anti-c, anti-E, anti-A, anti-B and some other antibodies.

Methods and material. A case of a pregnant woman who has been pregnant four times is presented. During the first pregnancy, she developed anti-D erythrocyte antibodies, and after the third pregnancy also additional anti-C antibodies. During the first pregnancy, hemolytic disease of fetus led to the intrauterine death of the fetus. The second child died one day after birth. The third and fourth fetuses required several intrauterine exchange transfusions due to high titers and great hemolytic activity of anti-D antibodies. In both newborns, exchange transfusions had to be performed after birth, and both received additional transfusions of concentrated erythrocytes because of anemia.

Conclusions. HDFN is a severe disorder that can be successfully prevented with appropriate legalized measures.

Downloads

Download data is not yet available.

References

Mollison PL, Engelfriet CP, Contreras M. Haemolytic disease of the fetus and newborn. In: Mollison PL, Engelfriet CP, Contreras M eds. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Science, 1997: 390–424.

Bowman JM. Historical overview: Haemolytic disease of the fetus and newborn. In: Kennedy HS, Wilson SM, Kelton JG eds. Perinatal transfusion medicine. Arlington: AABB, 1990: 1–52.

Carreras-Versico LA, Torres OW, Virgilio OS, Pizzolato M. Mild haemolytic disease of the newborn due to Anti-Lewis a. Vox Sang 1993; 64: 194–5.

Bharucha ZS, Joshi SR, Bhatia HM. Haemolytic disease of the newborn due to Anti-Leb. Vox Sang 1981; 41: 36–9.

Bricl I, Vogler A. Preprečevanje imunizacij anti-D z imunoprofilakso RhD. Med Razgl 2000; 39: Suppl 4–7: 195–8.

Vengelen-Tyler V. Perinatal concerns in transfusion practice. In: VengelenTyler V ed. Technical manual. Bethesda: AABB, 1999: 495–512.

Stedman CM, Baudin JC, White CA, Shanon-Cooper E. Use of the erithrocyte rosette test to screen for excessive fetomaternal haemorrhage in Rh negative women. Am J Obstet Gynecol 1986; 154: 1363–9.

Napier JAF. Haemolytic disease of the newborn. In: Napier JAF ed. Handbook of blood transfusion therapy. 2nd ed. Chichester, New York, Toronto, Brisbane, Singapore: John Wiley & Sons, 1995: 287–315.

Urbaniak SJ. The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol 1998; 105: Suppl 18: 11–8.

Garner SF, Gorick BD, Lai WYY et al. Prediction of the severity of the haemolytic disease of the newborn. Vox Sang 1995; 68: 169–76.

Larson PJ, Thorp JM, Miller RC, Hoffman M. The monocyte monolayer assay: a non-invasive technique for predicting the severity of in utero haemolysis. Am J Perinat 1995; 12: 157–60.

Skupski DW, Wolf CFW, Bussel JM. Fetal and perinatal transfusion therapy. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG eds. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996: 607–29.

Lapierre Y, Rigal D, Adam J et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30: 109–13.

How to Cite
1.
Bricl I, Ogrizek-Pelkič K, Vogler A. HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) – CASE REPORT. ZdravVestn [Internet]. 1 [cited 22Aug.2019];72(12). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/1890
Section
Professional Article

Most read articles by the same author(s)